Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Our AI scores Mannatech Inc every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Mannatech Inc is a small-cap company with a market capitalization of $16M. It ranks number 18 by market capitalization among the 28 Medicinal Chemicals & Botanical Products issuers in our coverage with a current forecast.
For MTEX, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 17.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 14.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, MTEX included.
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Medicinal Chemicals & Botanical Products peers listed below that report each metric.
| Metric | MTEX | Rank |
|---|---|---|
| Market Cap | $16M | 18/28 |
| P/E Ratio | 6.55x | – |
| EPS | $1.23 | – |
| Metric | MTEX | Rank |
|---|---|---|
| ROIC | 18.8% | 2/18 |
| Gross Margin | 74.0% | 3/21 |
| Operating Margin | 1.8% | 6/23 |
| EBT Margin | 3.1% | 5/23 |
| Tax Rate | 31.9% | – |
| Metric | MTEX | Rank |
|---|---|---|
| Current Ratio | 1.15x | 16/25 |
| Quick Ratio | 0.58x | 13/23 |
| Interest Coverage | 4.1x | 6/21 |
| Working Capital | $3M | 16/25 |
| Metric | MTEX | Rank |
|---|---|---|
| Operating Cash Flow | -$1M | 15/27 |
| OCF Growth YoY | -153.7% | 9/10 |
| Metric | MTEX | Rank |
|---|---|---|
| Inventory Turnover | 2.7x | 11/19 |
| Days Inventory | 135 days | 8/18 |
| Payables Period | 52 days | 9/17 |
| Metric | MTEX | Rank |
|---|---|---|
| Operating Income | $2M | 6/26 |
| SG&A Expense | $43M | 7/16 |
| Cost of Goods Sold | $26M | 13/22 |
| Metric | MTEX | Rank |
|---|---|---|
| Shares Outstanding | 2M | – |
| EPS Growth | -6.8% | 3/6 |
| Total Current Assets | $19M | |
| Cash & Short-term Investments | $6M | |
| Accounts Receivable | $140K | |
| Inventory | $10M | |
| Total Liabilities | $32M | |
| Short-term Debt | $13M |
Companies classified under the same SEC industry code as Mannatech Inc (Medicinal Chemicals & Botanical Products): 30 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| MTEX Mannatech Inc | $16M | |
| DFTX Definium Therapeutics, Inc. | $4.47B | |
| TRLV Trulieve Cannabis Corp. | $1.97B | |
| CRON Cronos Group Inc. | $1.33B | |
| TLRY Tilray Brands, Inc. | $432M | |
| SNDL Sndl Inc. | $355M | |
| ACB Aurora Cannabis Inc | $332M | |
| CGC Canopy Growth Corp | $276M | |
| USNA Usana Health Sciences Inc | $256M | |
| GLAS Glass House Brands Inc. | $196M | |
| MDWD Mediwound Ltd. | $171M | |
| NAGE Niagen Bioscience, Inc. | $164M | |
| AAWH Ascend Wellness Holdings, Inc. | $75M | |
| FTLF Fitlife Brands, Inc. | $75M | |
| CHUC Charlie's Holdings, Inc. | $31M | |
| BTMD Biote Corp. | $30M | |
| MRMD Marimed Inc. | $26M | |
| HYEX Healthy Extracts Inc. | $21M | |
| ADIA Adia Med, Inc. | $9M | |
| GLUC Glucose Health, Inc. | $9M | |
| BON Bon Natural Life Ltd | $7M | |
| NAII Natural Alternatives International Inc | $7M | |
| PLSH Panacea Life Sciences Holdings, Inc. | $6M | |
| AIBT Aibotics, Inc. | $3M | |
| CYAN Cyanotech Corp | $3M | |
| IMCC Im Cannabis Corp. | $980K | |
| NPHC Nutra Pharma Corp | $720K | |
| MEHA Functional Brands Inc. | $140K | |
| NTRR Neutra Corp. | N/A | |
| SNYRQ Synergy Chc Corp. | N/A |
Mannatech Inc is involved in the development and sale of health and wellness products, including dietary supplements and skin care products. The company operates globally, providing a range of ...
FLOWER MOUND, Texas, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX) announced the retirement of J. Stanley Fredrick from the Board of Directors (the "Board") of Mannatech, ...
There are no upcoming dividends for Mannatech.The last dividend paid last dividend payout June 29, 2023 and was $0.2. Mannatech has no upcoming dividends reported. The last reported dividend for ...
Our AI scores Mannatech Inc every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
For MTEX, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 17.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 14.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Mannatech Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
30 issuers in our coverage, MTEX included, share the SEC industry code Medicinal Chemicals & Botanical Products. The largest are: Definium Therapeutics, Inc. (DFTX), Trulieve Cannabis Corp. (TRLV), Cronos Group Inc. (CRON), Tilray Brands, Inc. (TLRY), Sndl Inc. (SNDL), Aurora Cannabis Inc (ACB).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.
